Cardiome Pharma Stock Price (NASDAQ:CRME)

Add to My Stocks
$4.7 $0.04 (0.86%) CRME stock closing price Jul 21, 2017 (Closing)
Prev Close* : $4.66
Market Cap:
$148.78M
Day Low: $4.57
52 Week Low: $2.35
Open: $4.64
Volume: 38544
Day High: $4.73
52 Week High: $5.48
Dividend:
N/A

Latest Stock Market News

Latest Articles

Cardiome Pharma News - From Partners

New Strong Sell Stocks for April 14th   by Zacks on Apr 14, 2016
New Strong Sell Stocks for April 12th   by Zacks on Apr 12, 2016
New Strong Sell Stocks for March 21st   by Zacks on Mar 21, 2016
Cardiome Closes US$23 Million Bought Deal Financing   by Marketwired on Aug 13, 2015

CRME Stockcharts

View CRME PE ratio, PS ratio stocks charts and compare with peers.
CRME Chart
Note: Compare Cardiome Pharma stock price history with the index and industry peers.

Cardiome Pharma Valuation

PS ratio (
price to sales ratio
)
6.42
PB ratio (
price to book ratio
)
5.57

Cardiome Pharma Financial Ratios

Asset Turnover
0.33
Receivables Turnover
3.59
Debt to Equity
0.69

CRME Industry Peers

Company Price Change (%)
Vernalis (VNLPY)0.580 (0%)
Merus Labs International (MSLI)1.30 (0%)
Medicure (MCUJF)6.470 (0%)
Steadymed (STDY)6.50.05 (0.78%)
United Therapeutics (UTHR)129.981.38 (1.05%)
Johnson & Johnson (JNJ)135.311.26 (0.92%)
Arca Biopharma (ABIO)2.430.05 (2.02%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cempra (CEMP)4.350.25 (6.1%)
Ignyta (RXDX)9.30.5 (5.68%)
PTC Therapeutics (PTCT)21.441.1 (5.41%)
Xencor (XNCR)23.780.78 (3.39%)
Adamis Pharma (ADMP)4.80.15 (3.23%)
Enanta Pharma (ENTA)37.471.05 (2.88%)
Tetraphase Pharmaceuticals (TTPH)8.090.22 (2.8%)
Top gainers from Medical-Drugs industry
* As of Jul 22, 2017
CompanyPriceChange (%)
Heron Therapeutics (HRTX)16.451.05 (6%)
ImmunoGen (IMGN)5.660.24 (4.07%)
CTI BioPharma (CTIC)3.410.12 (3.4%)
Catalyst Pharma (CPRX)2.950.1 (3.28%)
Pacira Pharma (PCRX)47.651.5 (3.05%)
BioCryst Pharma (BCRX)5.410.16 (2.87%)
GlycoMimetics (GLYC)11.50.33 (2.79%)
Top losers from Medical-Drugs industry
* As of Jul 22, 2017

CARDIOME PHARMA CORP Stock News - Partner Headlines

Cardiome Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues25.25M20.91M30.04M4.51M0.78M
Net Income-19.61M-24.46M-18.22M4.77M-18.31M
Total Operating Expense33.49M36.39M36.59M17.55M26.88M
view CARDIOME PHARMA CORP income statement
balance sheet20162015201420132012
Total Assets67.05M48.63M50.11M47.33M44.79M
Total Liabilities33.03M28.69M32.97M24.68M36.93M
Shareholders Equity34.02M19.93M17.13M22.64M7.85M
view CARDIOME PHARMA CORP balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-1.62M1.26M--1.81M2.29M
Net Cash From (Used By) Operating Activities-15.98M-16.3M-18.52M-16.76M-25.09M
Increase (Decrease) In Prop Plant And Equipment-0.01M-0.13M-0.52M-0.03M-0.14M
view CARDIOME PHARMA CORP cashflow statement

Cardiome Pharma Stock Message Board

Cardiome Pharma stock lost 0.86 %, and the last close price as of 21 Jul, 2017 is 4.7 for CRME stock. The total market value as denoted by 148.78M for Cardiome Pharma, is the market value of the company's outstanding shares. Cardiome Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Cardiome Pharma is worth a lot, it will most likely be reflected in an inflated Cardiome Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in Cardiome Pharma stock quote data shows the number of shares traded. For Ex: 38544 Cardiome Pharma shares were traded as of last trading day, as seen from Cardiome Pharma stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Cardiome Pharma stock price history, gives the entire historical data for CRME stock.